Latest in News & Research
JAK Inhibitors May Aid Hair Regrowth in Patients With Alopecia
Study shows safety and tolerability of JAK inhibitors acceptable
Skin Lightening Prevalent Among 'Skin of Color' Individuals
Skin lightening agent users have significantly higher composite colorism scores than nonusers
Is Lymecycline Superior to Doxycycline for Moderate-to-Severe Acne?
Lymecycline led to earlier reduction in number of lesions and severity of acne; shorter duration of therapy needed with lymecycline
Do Organ Transplant Recipients With cSCC Have Worse Outcomes?
Transplant recipients have increased rates of second cutaneous squamous cell carcinoma, metastasis, death from cutaneous squamous cell carcinoma
Exploring the Comorbidities Associated with Vitiligo
Comorbidities associated with vitiligo go beyond just the skin, making it vital that clinicians consider these associated conditions to ensure comprehensive care for their...
Prevalence of Atopic Diseases Increased in Sexually Diverse Individuals
Prevalence of atopic dermatitis, asthma, and allergic rhinitis increased compared with heterosexual individuals
Confirmatory Testing Underused for Tinea Capitis Diagnosis
Testing significantly less likely when diagnosis made by pediatrician, family practice clinicians
How Well Does 20 Percent Oxybutynin Hydrochloride Lotion Cut Palmar Sweat Volume?
20 percent oxybutynin hydrochloride lotion more effective than placebo for patients aged 12 years and older with primary palmar hyperhidrosis
Contributory Factors Identified for Discordant Severity Grading for Eczema, Psoriasis
Higher patient-graded severity for eczema, psoriasis linked to higher symptom expression, greater quality-of-life impairment
Lower Extremities Have Highest Surgical Site Infection Rates With Mohs Surgery
Findings especially for flap and graft closures
Chemotherapy-Induced Pseudocellulitis Described in Case Reports
Cases of true chemo-induced pseudocellulitis resembled infectious cellulitis; did not meet diagnostic criteria for known diagnoses
How Efficacious Is Microencapsulated BPO/Tretinoin for Acne?
Two studies show significant improvement in achieving Investigator Global Assessment success and change in inflammatory lesion count from baseline
Does Addiction Risk Affect Patient Choice of Pain Meds After Mohs Surgery?
Half of patients with pain level of 6.5 of 10 expressed preference for OTCs plus opioids when theoretical risk of addiction was low
Advancements in Treating Vitiligo
An overview of new and emerging treatments and research in vitiligo
Research Roundup: Vitiligo
Everything you need to know this month to stay up to date on the latest research in vitiligo
What’s New and Hot in Vitiligo
Treatment of vitiligo can be challenging, but with promising new treatments emerging, the therapeutic options for patients are increasing
Crisaborole Effective for Long-Term Maintenance in Mild-to-Moderate Eczema
Longer median time of flare-free maintenance, greater number of flare-free days, and lower mean number of flares
FDA Approves Litfulo for Teens, Adults With Alopecia Areata
Approval based on clinical trials, including ALLEGRO Phase 2b/3 trial involving 718 patients with alopecia areata
Does Spesolimab Control Generalized Pustular Psoriasis Flare Symptoms?
Spesolimab effects rapid control, with 60 percent of patients achieving GPPGA pustulation subscore of 0 and GPPGA total score of 0 or 1 by...
Systemic Sclerosis Sine Scleroderma Accounts for ~10 Percent With Systemic Sclerosis
Patients with ssSSC had lower prevalence of previous or current digital ulcers, puffy fingers compared to those with lcSSc, dcSSc
Eosinophilic Cellulitis Seems to Be Type 2 Inflammatory Disease
Preferential activation of JAK1/JAK2-STAT5 pathways observed in eosinophilic cellulitis
Moderate-to-Severe Psoriasis Tied to Lower Fertility Rates in Women
Additionally, risk for pregnancy loss is higher in patients with psoriasis
Current Approaches Inadequate to ID Culprit Drugs in Stevens-Johnson Syndrome
Algorithm for Drug Causality for Epidermal Necrolysis scoring was discordant for 28 cases, clearing 43 drugs labeled as allergens
24 of 1292